Schrödinger, Inc. (SDGR)

Market Cap	1.84B
Revenue (ttm)	216.67M
Net Income (ttm)	40.72M
Shares Out	72.68M
EPS (ttm)	0.54
PE Ratio	46.78
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,316,211
Open	24.50
Previous Close	24.38
Day's Range	24.42 - 26.75
52-Week Range	20.76 - 59.24
Beta	1.57
Analysts	Buy
Price Target	41.67 (+64.96%)
Earnings Date	May 1, 2024

About SDGR

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serv...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Feb 6, 2020
• Employees: 867
• Stock Exchange: NASDAQ
• Ticker Symbol: SDGR

Analyst Forecast

According to 9 analysts, the average rating for SDGR stock is "Buy." The 12-month stock price forecast is $41.67, which is an increase of 64.96% from the latest price.

Price Target

$41.67

(64.96% upside)

Analyst Consensus: Buy